- Total average daily volume for MarketAxess in November 2025 was $40.49 billion, which is a decrease of 9.9% compared to the same month last year.
- US high-grade bonds saw an average daily volume increase to $7.59 billion, up 16% year-over-year.
- US high-yield bonds experienced a significant growth with an average daily volume of $1.62 billion, an increase of 24% year-over-year.
- Emerging markets bonds had an average daily volume of $4.27 billion, marking a 12% rise from the previous year.
- Eurobonds showed strong performance with an average daily volume of $2.74 billion, climbing 37% compared to last year.
- Current analyst recommendations include 5 buy ratings, 8 hold ratings, and 1 sell rating for MarketAxess.
A look at Marketaxess Holdings Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
MarketAxess Holdings, Inc. operates a platform for bond trading in the U.S. and Europe. The company’s technology helps institutional and broker-dealer clients trade high-grade corporate and emerging markets bonds efficiently. The Smartkarma Smart Scores for MarketAxess Holdings indicate an overall positive outlook, with scores of 3 for Value, Dividend, Growth, and Momentum, and a score of 4 for Resilience.
Based on the Smart Scores, MarketAxess Holdings shows strength in resilience, indicating its ability to withstand market fluctuations. While the company scores moderately across other factors such as value, dividend, growth, and momentum, the overall outlook remains optimistic. Investors may find this balance of factors appealing for long-term investment potential in MarketAxess Holdings.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
